A Two-Part Phase 1 Study to Investigate the Safety and Tolerability of Supratherapeutic Dose of Zanubrutinib and Effect of Zanubrutinib on Cardiac Repolarization in Healthy Subjects
Clinical trial NCT03432884 · COMPLETED
Trial details
- NCT number
- NCT03432884
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-25
- Primary completion
- 2018-04-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.